Cytokinetics, Incorporated · NASDAQ:CYTK

Henderson John T received 272 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Jul 15, 2026 · Filed Jul 16, 2026

On Jul 15, 2026, Henderson John T (Director) received 272 Cytokinetics, Incorporated shares as an award at US$82.62 for US$22,473, leaving 78,360 shares. Filed Jul 16, 2026 (Form 4).

Awarded
272 shares
Price
US$82.62
Value
US$22,473
Holding after
78,360 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Common StockAward272US$82.6278,360Direct

Source

View original at SEC

Related